ViiV Healthcare Presents New Data Demonstrating Positive Real-World Impact of Its Innovative Long-Acting Injectables for HIV at IAS 2025

ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025

LONDON--(BUSINESS WIRE)--Jul 8, 2025-

Cambodia 2nd Asian country to rollout long-acting injectable HIV prevention option - Daily Good Morning Kashmir

Open the article to view the coverage from dailygoodmorningkashmir.com

FDA Approves Gilead Sciences’ Twice-Yearly Injection for HIV Prevention

The U.S. Food and Drug Administration (FDA) has granted […] The post FDA Approves Gilead Sciences’ Twice-Yearly Injection for HIV Prevention first appeared on GeneOnline News. The post FDA Approves Gilead Sciences’ Twice-Yearly Injection for HIV Prevention appeared first on GeneOnline News.